Plus, the Fed delivered a quarter-point cut, the OECD reduced its global growth outlook for 2019, and Airbnb is going public.
Read MorePlus, retail sales rose more than expected in August, Apple got a big downgrade, and the WeWork saga continues.
Read MoreI’m wrapping up my run through the Healthcare Equipment industry by looking at a stock that, like just about the entire rest of the industry, is at the extreme high end of a very long-term upward trend. Part of the reason that this industry has drawn my attention this week is because of the extended […]
Read MorePlus, the jobs report was mixed, U.K. Prime Minister Boris Johnson’s bad week gets worse, Apple is taking advantage of cheap debt, and Facebook can now be used as a dating app.
Read MoreThis week, I’ve been turning my focus to Healthcare stocks, most particularly to the Healthcare Equipment industry of that sector. The most-established stocks in the industry all seem to be at or very near to all-time high levels – something that I believe is driven by broad fundamental strength among most of these companies as […]
Read MoreIn the last few days, the Healthcare sector has drawn a little extra attention, since it has been one of the best-performing sectors in the market in the last month while other, more cyclical sectors have seen increasing bearish turns due to trade-related uncertainty and volatility. Healthcare stocks certainly do have some sensitivity to trade […]
Read MoreAs an investor that prefers to focus on value, my preference is to emphasize stocks that are currently trading at significant discounts to their basic valuation metrics. That usually means that most of my attention is directed on stocks that are also trading at or near to yearly or historical lows. That also means that […]
Read MoreFor growth investors, stocks making new all-time highs are usually seen as the best kinds of stocks to buy. When new all-time highs happen at the top of a long-term upward trend, many of those same investors get even more excited, because traditional trend analysis usually suggests that those are among the highest-probability signals to […]
Read MoreTrade Setup Buy Target $3.49 Sell Target $4.16 Trailing Stop 20% Conformis, Inc., a medical technology company, develops, manufactures, and sells joint replacement implants. The company offers customized knee replacement products, including iTotal CR, a cruciate-retaining product; iTotal PS, a posterior cruciate ligament substituting product; iDuo, a customized bicompartmental knee replacement system; and iUni, a […]
Read MoreAnd 2 of these stocks could still see double-digit upside over the next twelve months.
Read MoreThe tech- and pharma-centric Nasdaq index has certainly endured volatility recently, but there’s no denying it’s experienced a stunning overall rally this year. While it has dropped 6.1% over the last month to the lowest levels since March, it’s still up a strong 15% since the last close of 2018 and up 16.4% from the […]
Read MoreEDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases worldwide. The company operates in two divisions: High Intensity Focused Ultrasound (HIFU), and Urology Devices and Services (UDS). The HIFU division develops, manufactures, and markets devices for the minimally invasive […]
Read MoreShares of Edwards Lifesciences Corp. (EW) surged on Monday after the medical device firm reported results from an important clinical trial. The stock posted one of its best days in history, rocketing to its highest level ever as a publicly traded company. Despite Monday’s news, the company’s gains may entice investors to overreact with enormous […]
Read MoreThe month of February is now in the bag, and investors have plenty of reasons to celebrate. Despite the Dow Jones Industrial Average closing slightly lower on Thursday for its third straight daily loss, the index still managed an 11.1% gain in February. That marks the best two-month beginning of a year since 1987 when […]
Read More